Biomarkers for Evaluating Spine Treatment
The BEST Trial (Biomarkers for Evaluating Spine Treatments) is a NIAMS-sponsored clinical trial being conducted through the NIH HEAL Initiative's Back Pain Consortium (BACPAC) Research Program. The primary objective of this trial is to inform a precision medicine approach to the treatment of Chronic Low-Back Pain by estimating an algorithm for optimally assigning treatments based on an individual's phenotypic markers and response to treatment.
Website: https://www.besttrial.org/
Acronym: BEST
Clinical Centers: 12
Participants: 1,014
Beginning:
Ending:
Funding: NIAMS
Study Design: Sequential Multiple Assignment Randomized Trial (SMART)